SAB BIOTHERAPEUTICS, INC. (SABSW) Free cash flow 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$45.7MFY2025 · since FY2020: -$2.7M → -$45.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.7M | -32.0% |
| FY2024 | -$34.6M | -36.8% |
| FY2023 | -$25.3M | +1.2% |
| FY2022 | -$25.6M | -186.1% |
| FY2021 | -$9.0M | -228.5% |
| FY2020 | -$2.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Operating cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →